secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2021-11-02T23:59:59+00:00
Accession:  0001171520-21-000432
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro appoints renowned neurosurgeon Dr. Linda M. Liau to Board
--------------------------------------------------------------------------

- Board expanded from 7 to 8 members; Dr. Liau appointed to newly created directorship effective Nov 2, 2021.
- Dr. Liau is Professor and W. Eugene Stern Chair of Neurosurgery at UCLA, Co-Director of UCLA Brain Tumor Center.
- She receives $40,000 annual retainer and initial equity grant valued at $120,000 vesting over one year.
- Compensation includes annual equity grants of $120,000 on the day after each annual meeting.
- No arrangements with any other person; no related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152021000432/0001171520-21-000432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152021000432/eps9887.htm
  HTML page:      https://secwatch.observer/filing/0001171520-21-000432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer